Organophosphorus compounds are highly toxic irreversible inhibitors of cholinesterases, causing the disruption of cholinergic functions. Treatment of poisoning includes causal antidotes (oximes) used as reactivators of inhibited cholinesterases, such as pralidoxime. In this work, new halogenated oxime reactivators derived from pralidoxime were developed. The oximes were designed with a halogen substituent that lowers the pK a and enhances oximate formation. Their synthesis, stability, physicochemical properties, inhibition of native cholinesterases, and in vitro reactivation of organophosphate-inhibited cholinesterases were investigated. A series of C4 and C6 halogenated oximes showed instability and their degradation products were identified, while C3 and C5 oximes exhibited sufficient stability for the evaluation. C3 oximes displayed overall low inhibition of cholinesterases and high reactivation ability of organophosphate-inhibited cholinesterases compared to pralidoxime, indicating the significant impact of halogen substitution on reactivation ability.

University Hospital in Hradec Kralove Biomedical Research Centre Sokolska 581 500 05 Hradec Kralove Czech Republic

University of Hradec Kralove Faculty of Science Department of Chemistry Rokitanskeho 62 500 03 Hradec Kralove Czech Republic

See more in PubMed

Chambers J. E.; Dail M. B.; Meek E. C. Oxime-Mediated Reactivation of Organophosphate-Inhibited Acetylcholinesterase with Emphasis on Centrally-Active Oximes. Neuropharmacology 2020, 175, 108201.10.1016/j.neuropharm.2020.108201. PubMed DOI PMC

Marrs T. C. Organophosphate Poisoning. Pharmacol. Ther. 1993, 58 (1), 51–66. 10.1016/0163-7258(93)90066-M. PubMed DOI

Chai P. R.; Hayes B. D.; Erickson T. B.; Boyer E. W. Novichok Agents: A Historical, Current, and Toxicological Perspective. Toxicol. Commun. 2018, 2 (1), 45–48. 10.1080/24734306.2018.1475151. PubMed DOI PMC

Hoenig S. L.Compendium of Chemical Warfare Agents; Springer Science & Business Media, 2006.

Howes L. Novichok Compound Poisoned Navalny. Chem. Enf. News 2020, 98 (35), 5–5. 10.1021/cen-09835-scicon3. DOI

Mew E. J.; Padmanathan P.; Konradsen F.; Eddleston M.; Chang S.-S.; Phillips M. R.; Gunnell D. The Global Burden of Fatal Self-Poisoning with Pesticides 2006–15: Systematic Review. J. Affec. Disord 2017, 219, 93–104. 10.1016/j.jad.2017.05.002. PubMed DOI

Malinak D.; Korabecny J.; Soukup O.; Gorecki L.; Nepovimova E.; Psotka M.; Dolezal R.; Nguyen T. D.; Mezeiova E.; Musilek K.; Kuca K. A Review of the Synthesis of Quaternary Acetylcholinesterase Reactivators. Curr. Org. Chem. 2018, 22 (16), 1619–1648. 10.2174/1385272822666180711123529. DOI

Wilson I. B.; Ginsburg S. A Powerful Reactivator of Alkylphosphate-Inhibited Acetylcholinesterase. Biochim. Biophys. Acta 1955, 18, 168–170. 10.1016/0006-3002(55)90040-8. PubMed DOI

Ginsburg S.; Wilson I. B. Oximes of the Pyridine Series1. J. Am. Chem. Soc. 1957, 79 (2), 481–485. 10.1021/ja01559a067. DOI

Markovac A.; Stevens C. L.; Ash A. B.; Hackley B. E. Jr Synthesis of Oximes. III. Iodine Dimethyl Sulfoxide Reaction with Methylpyridines. J. Org. Chem. 1970, 35 (3), 841–843. 10.1021/jo00828a074. DOI

Markovac A.; Ash A. B.; Stevens C. L.; Hackley B. E. Jr; Steinberg G. M. Synthesis of Oxirnes. IV. 2-Pyridinealdoxime Methiodides from 2-Picoline Methiodides. J. Heterocycl. Chem. 1977, 14 (1), 19–26. 10.1002/jhet.5570140104. DOI

Arena F.; Manna F.; Pizza C.; Stein M. L.; Grifantini M. Structure-Activity Relationships in Reactivators of Organophosphorus-Inhibited Acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine Methiodides. J. Med. Chem. 1975, 18 (11), 1147–1150. 10.1021/jm00245a022. PubMed DOI

Racakova V.; Hrabinova M.; Jun D.; Kuca K. Substituted Monoquaternary Oximes as Reactivators of Cyclosarin-and Chlorpyrifos-Inhibited Acetylcholinesterase. Arh. Hig. Rada. Toksikol. 2006, 57 (4), 387–390. PubMed

Musilek K.; Kucera J.; Jun D.; Dohnal V.; Opletalova V.; Kuca K. Monoquaternary Pyridinium Salts with Modified Side Chain—Synthesis and Evaluation on Model of Tabun- and Paraoxon-Inhibited Acetylcholinesterase. Bioorg. Med. Chem. 2008, 16 (17), 8218–8223. 10.1016/j.bmc.2008.07.036. PubMed DOI

Okuno S.; Sakurada K.; Ohta H.; Ikegaya H.; Kazui Y.; Akutsu T.; Takatori T.; Iwadate K. Blood-Brain Barrier Penetration of Novel Pyridinealdoxime Methiodide (PAM)-Type Oximes Examined by Brain Microdialysis with LC-MS/MS. Toxicol. Appl. Pharmacol. 2008, 227 (1), 8–15. 10.1016/j.taap.2007.09.021. PubMed DOI

Quinn D. M.; Topczewski J. J.. Compounds and Methods to Treat Organophosphorus Poisoning. US20160151342A1, 2016. https://patents.google.com/patent/US20160151342A1/en.

Musilek K.; Dolezal M.; Gunn-Moore F.; Kuca K. Design, Evaluation and Structure-Activity Relationship Studies of the AChE Reactivators against Organophosphorus Pesticides. Med. Res. Rev. 2011, 31 (4), 548–575. 10.1002/med.20192. PubMed DOI

Gambino A.; Burnett J. C.; Koide K. Methyl Scanning and Revised Binding Mode of 2-Pralidoxime, an Antidote for Nerve Agent Poisoning. ACS Med. Chem. Lett. 2020, 11 (10), 1893–1898. 10.1021/acsmedchemlett.9b00586. PubMed DOI PMC

Zorbaz T.; Kovarik Z. Neuropharmacology: Oxime Antidotes for Organophosphate Pesticide and Nerve Agent Poisoning. Period. Biol. 2020, 121–122, 35–54. 10.18054/pb.v121-122i1-2.10623. DOI

Prchalova E.; Kohoutova Z.; Knittelova K.; Malinak D.; Musilek K. Strategies for Enhanced Bioavailability of Oxime Reactivators in the Central Nervous System. Arch. Toxicol. 2023, 97 (11), 2839–2860. 10.1007/s00204-023-03587-0. PubMed DOI

Zorbaz T.; Malinak D.; Marakovic N.; Macek Hrvat N.; Zandona A.; Novotny M.; Skarka A.; Andrýs R.; Benkova M.; Soukup O.; Katalinić M.; Kuca K.; Kovarik Z.; Musilek K.. Pyridinium Oximes with Ortho-Positioned Chlorine Moiety Exhibit Improved Physicochemical Properties and Efficient Reactivation of Human Acetylcholinesterase Inhibited by Several Nerve Agents. J. Med. Chem. 2018, 61, 10753–1076610.1021/acs.jmedchem.8b01398. PubMed DOI

Zorbaz T.; Malinak D.; Hofmanova T.; Maraković N.; Žunec S.; Hrvat N. M.; Andrys R.; Psotka M.; Zandona A.; Svobodova J.; Prchal L.; Fingler S.; Katalinić M.; Kovarik Z.; Musilek K. Halogen Substituents Enhance Oxime Nucleophilicity for Reactivation of Cholinesterases Inhibited by Nerve Agents. Eur. J. Med. Chem. 2022, 238, 114377.10.1016/j.ejmech.2022.114377. PubMed DOI

Joule J. A.; Mills K.. Heterocyclic Chemistry, 5th ed. 2010.

Davies D. T.Aromatic Heterocyclic Chemistry, 1st ed.; Oxford University Press: Oxford, 1992.

Bowler J. T.; Wong F. M.; Gronert S.; Keeffe J. R.; Wu W. Reactivity in the Nucleophilic Aromatic Substitution Reactions of Pyridinium Ions. Org. Biomol. Chem. 2014, 12 (32), 6175–6180. 10.1039/C4OB00946K. PubMed DOI PMC

Bunnett J. F. A New Factor Affecting Reactivity in Bimolecular Nucleophilic Displacement Reactions 1. J. Am. Chem. Soc. 1957, 79 (22), 5969–5974. 10.1021/ja01579a034. DOI

Handl J.; Malinak D.; Capek J.; Andrys R.; Rousarova E.; Hauschke M.; Bruckova L.; Cesla P.; Rousar T.; Musilek K. Effects of Charged Oxime Reactivators on the HK-2 Cell Line in Renal Toxicity Screening. Chem. Res. Toxicol. 2021, 34 (3), 699–703. 10.1021/acs.chemrestox.0c00489. PubMed DOI

Prchalova E.; Andrys R.; Pejchal J.; Kohoutova Z.; Knittelova K.; Hofmanova T.; Skarka A.; Dlabkova A.; Psotka M.; Prchal L.; Musilek K.; Zdarova Karasova J.; Malinak D. Brominated Oxime Nucleophiles Are Efficiently Reactivating Cholinesterases Inhibited by Nerve Agents. Arch. Toxicol. 2024, 98 (9), 2937–2952. 10.1007/s00204-024-03791-6. PubMed DOI

Chen H.; Yang Y.; Wang L.; Niu Y.; Guo M.; Ren X.; Zhao W.; Tang X.; Wang G. Slicing and Splicing of Bromodifluoro-N-Arylacetamides: Dearomatization and Difunctionalization of Pyridines. Org. Lett. 2020, 22 (16), 6610–6616. 10.1021/acs.orglett.0c02368. PubMed DOI

Yang Q.-Y.; Lehn J.-M. Bright White-Light Emission from a Single Organic Compound in the Solid State. Angew. Chem., Int. Ed. 2014, 53 (18), 4572–4577. 10.1002/anie.201400155. PubMed DOI

Payne C.; Kass S. R.. Structural Considerations for Charge-enhanced Brønsted Acid Catalysts. J. Phys. Org. Chem. 2020, 33 ( (8), ), e4069.10.1002/poc.4069. DOI

Musil K.; Florianova V.; Bucek P.; Dohnal V.; Kuca K.; Musilek K. Development and Validation of a FIA/UV-Vis Method for pKa Determination of Oxime Based Acetylcholinesterase Reactivators - ScienceDirect. J. Pharm. Biomed. Anal. 2016, 117, 240–246. 10.1016/j.jpba.2015.09.010. PubMed DOI

Terrier F.; Rodriguez-Dafonte P.; Le Guevel E.; Moutiers G. Revisiting the Reactivity of Oximate α-Nucleophiles with Electrophilic Phosphorus Centers. Relevance to Detoxification of Sarin, Soman and DFP under Mild Conditions. Org. Biomol. Chem. 2006, 4 (23), 4352–4363. 10.1039/B609658C. PubMed DOI

Driant T.; Nachon F.; Ollivier C.; Renard P.-Y.; Derat E. On the Influence of the Protonation States of Active Site Residues on AChE Reactivation: A QM/MM Approach. ChemBioChem. 2017, 18 (7), 666–675. 10.1002/cbic.201600646. PubMed DOI

Kohoutova Z.; Malinak D.; Andrys R.; Svobodova J.; Psotka M.; Schmidt M.; Prchal L.; Musilek K. Charged Pyridinium Oximes with Thiocarboxamide Moiety Are Equally or Less Effective Reactivators of Organophosphate-Inhibited Cholinesterases Compared to Analogous Carboxamides. J. Enzym. Inhib. Med. Chem. 2022, 37 (1), 760–767. 10.1080/14756366.2022.2041628. PubMed DOI PMC

Bennett J. P.; Meek E. C.; Chambers J. E. Reactivation by Novel Pyridinium Oximes of Rat Serum and Skeletal Muscle Acetylcholinesterase Inhibited by Organophosphates. J. Biochem. Mol. Toxicol. 2024, 38 (7), e2375010.1002/jbt.23750. PubMed DOI PMC

Gorecki L.; Hepnarova V.; Karasova J. Z.; Hrabinova M.; Courageux C.; Dias J.; Kucera T.; Kobrlova T.; Muckova L.; Prchal L.; Malinak D.; Jun D.; Musilek K.; Worek F.; Nachon F.; Soukup O.; Korabecny J. Development of Versatile and Potent Monoquaternary Reactivators of Acetylcholinesterase. Arch. Toxicol. 2021, 95 (3), 985–1001. 10.1007/s00204-021-02981-w. PubMed DOI

Valiveti A. K.; Bhalerao U. M.; Acharya J.; Karade H. N.; Acharya B. N.; Raviraju G.; Halve A. K.; Kaushik M. P. Synthesis and in Vitro Kinetic Evaluation of N-Thiazolylacetamido Monoquaternary Pyridinium Oximes as Reactivators of Sarin, O-Ethylsarin and VX Inhibited Human Acetylcholinesterase (hAChE). Bioorg. Med. Chem. 2015, 23 (15), 4899–4910. 10.1016/j.bmc.2015.05.027. PubMed DOI